TopgOptions

OCGN Ocugen new Covid-19 Vaccine and Price Target

看多
NASDAQ:OCGN   Ocugen, Inc.
OCGN Ocugen partnered with Bharat Biotech for Covaxin, the first COVID vaccine developed in India to receive emergency authorization.

With the COVID significant rise in cases, hospitalizations and deaths over the last two weeks, vaccines producers are rising once again.

My short term Price Target is 10.30usd


免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。